Surgery Partners Provides Update on 2017 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- Oil rises 1% on US-Iran deal doubts; IEA warns of supply glut
Surgery Partners (SGRY) PT Lowered to $13 at Jefferies Following 3Q
November 1, 2017 8:21 AM EDTJefferies lowered its price target on Surgery Partners (NASDAQ: SGRY) to $13.00 (from $16.00) while maintaining a Buy rating following the company's 3Q earnings report. Unlike many HC services peers, SGRY managed in Q3 to beat on top-line ($330MM vs $302MM consensus) and deliver inline EBITDA... More
